We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
UK pharmacy chain has increased market share but detractors say tired stores have dented its reputation
Plus, European Spacs struggle to strike mergers and EY pays up for its cheating scandal
Owner of UK pharmacy and beauty group blames market turmoil for bids below its expectations
Chemist chain is not a business that can be fixed by some fancy financing
A successful bid with Apollo could lead to Boots becoming a high street name in India
Offer values UK group at between £5bn and £6bn and will allow US parent to keep a minority stake
Private equity group teams up with India’s largest company in attempt to buy UK pharmacy chain
Bain Capital and CVC Capital failed to make bid ahead of deadline last week
Any buyer of the UK high street chain should quickly find ways to improve its fortunes
Private equity companies are jointly considering an approach for UK chemist, say insiders
Dire warnings of empty shelves have failed to materialise as many companies successfully navigate logistical challenges
Investment bank will weigh possible sale or spin-off of pharmacy chain
Boots and Ocado among UK brands denying they ‘approved’ fintech company’s affiliate bitcoin scheme
British Property Federation says some tenants refuse to compromise over unpaid bills
Fresh blow to UK high street as Sunak’s stimulus package comes under fire
Pharmacist reports far fewer shoppers even as most outlets stayed open during lockdown
Landlords angered by non-payment as stores remain open during lockdown
High-street pharmacy chain seeks to cut costs and automate processes
Walgreens-owned retailer seeks to revamp beauty business in face of tough competition
Retailer says any closures will be focused on reducing duplication with pharmacies in line of fire
US-based group also unveils $1bn cost-cutting programme
Analysts are making a living showing companies how to integrate data into decisions
High street pharmacy charged £3,220 for pain-relieving mouthwash that can cost £93
The arrival of a multi-stage life brings challenges for managers, writes Andrew Hill
International Edition
